PQA has appointed 15 individuals from member organizations to serve on a technical expert panel (TEP) to review and provide input on draft specification for a health plan performance measure concept: COPD (chronic obstructive pulmonary disease) Treatment Ratio (CTR).
PQA offers a variety of student and professional programs, including experiential rotations, internships and fellowships. Each is focused on providing healthcare quality experience to diverse individuals from diverse disciplines.
PQA offers a competitive Advanced Pharmacy Practice Experiential (APPE) Rotation for pharmacy students, which provides experiential learning opportunities in non-profit association management, medication use quality education, communications, research and performance measurement. PQA works with individual students to align their rotation experience with desired career goals and interests. Applications for the 2023-24 year are now being accepted. You can apply here. Visit our Student Programs page for more information.
The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.
PQA has been busy this year advancing the quality of medication use through measure development and stewardship, education, research and convening. Thank you for your engagement and participation in our work that supports better medication use and high-quality care.
The 2022 PQA Annual Meeting hosted a general session to discuss recent changes across Centers for Medicare & Medicaid (CMS) quality programs and future implications.
The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.
RAND convened a technical expert panel (TEP) in February 2022 to gather input about potentially developing a measure to capture value-based care arrangements (VBAs) that Medicare Advantage (MA) organizations have with contracted providers. The Centers for Medicare and Medicaid (CMS) could consider including such a measure in future MA and Part D Star Ratings.
PQA’s talented staff is dedicated to improving medication safety, adherence and appropriate use. As experts in measure development, research, education and convening, they lead the implementation of PQA’s quality initiatives to support better medication use and high-quality care. This blog is one in a series profiling PQA's staff.
PQA has begun developing a health plan performance measure for chronic obstructive pulmonary disease (COPD). COPD is a high-burden and expensive condition, so ensuring effective, high-quality treatment is a priority for patients and those who care for them.
PQA, the Pharmacy Quality Alliance, has begun developing a health plan performance measure for chronic obstructive pulmonary disease (COPD).
As the summer winds down, we are quickly approaching the end of 2022. PQA has been busy this year, in collaboration with our members, advancing the quality of medication use through measure development and stewardship, education, research and convening.
The PQA Quality Essentials Webinar provides education on the fundamentals of quality measurement, which is important for effective measure implementation and performance, and information about where and how PQA quality measures are used.
We are excited to announce that we will be open registration for the 2022 PQA Leadership Summit later this month. This year's summit will take place November 10-11 in Arlington, Va., and explore quality and value in medication use from patient, provider, purchaser, payer and industry perspectives.
PQA follows a systematic, transparent and consensus-based development process to ensure that measures are important, scientifically acceptable, feasible and usable. However, the measurement lifecycle does not end when a measure is endorsed.
This guest blog is one in a series by sponsors of the 2022 PQA Annual Meeting on the utilization of the EQUIPP platform to promote performance improvement on medication-related quality measures while engaging transparency between health plans and pharmacies. The views shared in this series are those of the author and do not reflect any PQA positions.
Quality measures are standards for measuring the performance of health care providers to care for patients and populations. PQA develops and stewards measures focused on medication use.
Recently published research conducted by the National Pharmaceutical Council, PQA and the University of Rhode Island measured the impact of patient nonadherence to oral anticancer medications. The study findings have been published in the Journal of Managed Care & Specialty Pharmacy.
The PQA Postdoctoral Executive Fellowship helps produce the next generation of leaders in health care quality through a full-time, 12-month program. Executive Fellows collaborate with PQA staff, members and other stakeholders on a variety of initiatives to improve medication use quality. During the fellowship, individuals will expand their skills and experience in project management, quality measure design and implementation, non-profit administration and association management, and health care quality research.
Biopharmaceutical innovation has led to an increase in the availability of oral medications to treat cancer. Oral anticancer medications (OAMs) are much more convenient for patients and avoid the inconvenience and administration costs of having to receive treatment at a doctor’s office or outpatient infusion center, allowing patients to self-administer oral medication at home. One challenge with OAMs however is nonadherence. Research has shown that almost half of patients on OAMs do not take their medications as prescribed.
